Emerald Advisers’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-12,655
Closed -$19.2M 255
2018
Q3
$19.2M Sell
12,655
-2,012
-14% -$3.06M 0.71% 64
2018
Q2
$23M Buy
+14,667
New +$23M 0.87% 41